BioSante completes direct public offering

BioSante Pharmaceuticals Inc. (NASDAQ:BPAX), Lincolnshire, Ill. Business: Drug delivery, Endocrine, Genitourinary Date completed: 6/23/10 Type: Direct public offering Raised: $15 million Units: 7.1 mi...